Stephen Dodge

SVP, Global Medical Affairs at Madrigal Pharmaceuticals

Dr. Dodge has over 20 years of medical affairs leadership across both small biotech and large pharma, including roles at Intercept, Merck, Novo Nordisk and Novartis. He has more than 10 years working directly in hepatology and GI, as well as metabolic disease, building out medical affairs capabilities to support market entry in new therapeutic areas across 20+ launches.

Org chart

Manager

Bill Sibold

CEO

Peers

Alex Howarth

CFO

Dominic F. Labriola

Chief Data and Analytics Officer

Robert Waltermire

Chief Pharmaceutical Development Officer

Timeline

SVP, Global Medical Affairs
Current role

View in org chart